================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT


                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934


                        DATE OF REPORT: NOVEMBER 26, 2002
                        (DATE OF EARLIEST EVENT REPORTED)



                            VASCULAR SOLUTIONS, INC.
             (Exact name of registrant as specified in its charter)


                         Commission File Number: 0-27605
                                   -----------


       MINNESOTA                                           41-1859679
(State of Incorporation)                       (IRS Employer Identification No.)

                             2495 XENIUM LANE NORTH
                          MINNEAPOLIS, MINNESOTA 55441
                    (Address of Principal Executive Offices)

                                 (763) 656-4300
               (Registrant's telephone number, including are code)



================================================================================



ITEM 5. OTHER EVENTS.

On November 26, 2002, Vascular Solutions issued a press release announcing the
settlement of patent litigation with Datascope. A copy of the press release is
included herein as Exhibit 99.1.

ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS

Exhibit 99.1 Press Release, dated November 26, 2002 announcing the settlement of
patent litigation with Datascope

Exhibit 99.2 Settlement Agreement dated November 26, 2002 by and between
Vascular Solutions and Datascope



                                    SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                                     VASCULAR SOLUTIONS, INC.


Date:  November 26, 2002                             By: /s/ Howard Root
                                                         -----------------------
                                                         Howard Root
                                                         CHIEF EXECUTIVE OFFICER